Schedule 13G ownership disclosure

PLIANT THERAPEUTICS INC

Common Stock · CUSIP: 729139105

Event date: 2025-12-31

Filing-level shares
545,228
Percent of class
0.9%
  • Morgan Stanley

    Shares: 545,228 · Class: 0.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000895421-26-000001
Form type
SCHEDULE 13G/A
Filer
MORGAN STANLEY
CIK
CIK 895421
Filed
Jan 08, 2026
Reporting period
Dec 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub